Vanessa Redecke

5.7k total citations · 2 hit papers
29 papers, 4.5k citations indexed

About

Vanessa Redecke is a scholar working on Immunology, Microbiology and Molecular Biology. According to data from OpenAlex, Vanessa Redecke has authored 29 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Immunology, 7 papers in Microbiology and 4 papers in Molecular Biology. Recurrent topics in Vanessa Redecke's work include Immune Response and Inflammation (16 papers), Immune Cell Function and Interaction (6 papers) and Immunotherapy and Immune Responses (6 papers). Vanessa Redecke is often cited by papers focused on Immune Response and Inflammation (16 papers), Immune Cell Function and Interaction (6 papers) and Immunotherapy and Immune Responses (6 papers). Vanessa Redecke collaborates with scholars based in United States, Germany and Japan. Vanessa Redecke's co-authors include Hans Häcker, Hermann Wagner, Eyal Raz, Grayson B. Lipford, Shizuo Akira, Carsten J. Kirschning, Stefan Bauer, Susanne Hausmann, Paula M. Pitha and Georg Häcker and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Vanessa Redecke

29 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition

2001 1.3k citations Carsten J. Kirschning, Hans Häcker et al. Proceedings of the National Academy of Sciences profile →
Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6

2005 773 citations Hans Häcker, Vanessa Redecke et al. Nature profile →

Peers

Countries citing papers authored by Vanessa Redecke

Since Specialization

Citations

This map shows the geographic impact of Vanessa Redecke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanessa Redecke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanessa Redecke more than expected).

Fields of papers citing papers by Vanessa Redecke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vanessa Redecke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanessa Redecke. The network helps show where Vanessa Redecke may publish in the future.

Co-authorship network of co-authors of Vanessa Redecke

This figure shows the co-authorship network connecting the top 25 collaborators of Vanessa Redecke. A scholar is included among the top collaborators of Vanessa Redecke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vanessa Redecke. Vanessa Redecke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	De novo Membranous Nephropathy in Renal Allografts is Associated With Protocadherin FAT1 2024 ·Kidney International Reports ·Laith Al‐Rabadi, Aaron J. Storey, Christopher P. Larsen, Samar Hassen, Mónica P. Revelo, Ravi Shankar Singh, Eszter Lázár‐Molnár, (unknown), (unknown), Frank Darras, (unknown), (unknown), (unknown), Vanessa Redecke, Manish Talwar, (unknown), Laurence H. Beck, Tiffany Caza	3
2	A phospho-tyrosine–based signaling module using SPOP, CSK, and LYN controls TLR-induced IRF activity 2022 ·Science Advances ·Kazuki Tawaratsumida, Vanessa Redecke, Ruiqiong Wu, Jeeba A. Kuriakose, Jill J. Bouchard, Tanja Mittag, Brian K. Lohman, Ashutosh Mishra, Anthony A. High, Hans Häcker	9
3	A rapid and affordable point of care test for antibodies against SARS-CoV-2 based on hemagglutination and artificial intelligence interpretation 2021 ·Scientific Reports ·Vanessa Redecke, Kazuki Tawaratsumida, Erin T. Larragoite, Elizabeth S. C. P. Williams, Vicente Planelles, Adam M. Spivak, (unknown), Marc Elgort, (unknown), (unknown), (unknown), (unknown), Patricia Slev, (unknown), Mark E. Astill, Hans Häcker	7
4	Patrolling monocytes promote the pathogenesis of early lupus-like glomerulonephritis 2019 ·Journal of Clinical Investigation ·Jeeba A. Kuriakose, Vanessa Redecke, Cliff Guy, Jingran Zhou, Ruiqiong Wu, Sirish K. Ippagunta, Heather Tillman, Patrick D. Walker, Peter Vogel, Hans Häcker	68
5	Type I Interferon Protects against Pneumococcal Invasive Disease by Inhibiting Bacterial Transmigration across the Lung 2013 ·PLoS Pathogens ·Kim S. LeMessurier, Hans Häcker, Liying Chi, Elaine Tuomanen, Vanessa Redecke	84
6	Hematopoietic progenitor cell lines with myeloid and lymphoid potential 2013 ·Nature Methods ·Vanessa Redecke, Ruiqiong Wu, Jingran Zhou, David Finkelstein, Vandana Chaturvedi, Anthony A. High, Hans Häcker	102
7	NIK Prevents the Development of Hypereosinophilic Syndrome-like Disease in Mice Independent of IKKα Activation 2012 ·The Journal of Immunology ·Hans Häcker, Liying Chi, Jerold E. Rehg, Vanessa Redecke	23
8	A20-binding inhibitor of NF-κB (ABIN1) controls Toll-like receptor-mediated CCAAT/enhancer-binding protein β activation and protects from inflammatory disease 2011 ·Proceedings of the National Academy of Sciences ·Jingran Zhou, Ruiqiong Wu, Anthony A. High, Clive A. Slaughter, David Finkelstein, Jerold E. Rehg, Vanessa Redecke, Hans Häcker	80
9	The E3 Ubiquitin Ligase Mind Bomb-2 (MIB2) Protein Controls B-cell CLL/Lymphoma 10 (BCL10)-dependent NF-κB Activation 2011 ·Journal of Biological Chemistry ·Cinthia Carolina Stempin, Liying Chi, Juan P. Giraldo‐Vela, Anthony A. High, Hans Häcker, Vanessa Redecke	38
10	Induction and Inhibition of the Th2 Phenotype Spread: Implications for Childhood Asthma 2005 ·The Journal of Immunology ·Tomoko Hayashi, Xing Gong, Cyprian C. Rossetto, Carol Shen, Kenji Takabayashi, Vanessa Redecke, Hans L. Spiegelberg, David H. Broide, Eyal Raz	13
11	Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6 breakdown → 2005 ·Nature ·Hans Häcker, Vanessa Redecke, Blagoy Blagoev, Irina Kratchmarova, Li‐Chung Hsu, Gang Greg Wang, Mark P. Kamps, Eyal Raz, Hermann Wagner, Georg Häcker, Matthias Mann, Michael Karin	773
12	EMMPRIN (CD 147) is a central activator of extracellular matrix degradation by Chlamydia pneumoniae-infected monocytes. 2005 ·Thrombosis and Haemostasis ·Roland Schmidt, Vanessa Redecke, (unknown), Nina Wantia, Thomas Miethke, Steffen Maßberg, (unknown), Franz‐Josef Neumann, Albert Schömig, Andreas E. May	29
13	Toll-like receptor ligands: hygiene, atopy and therapeutic implications 2004 ·Current Opinion in Allergy and Clinical Immunology ·Anthony A. Horner, Vanessa Redecke, Eyal Raz	27
14	Immunoglobulin-like transcripts ILT2, ILT3 and ILT7 are expressed by human dendritic cells and down-regulated following activation 2004 ·Gene ·Xinsheng Ju, Christine Hacker, (unknown), Vanessa Redecke, Thomas Berger, Gerold Schuler, Hermann Wagner, Grayson B. Lipford, Martin Zenke	66
15	Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: Activation of Toll-like receptor 7 2003 ·Proceedings of the National Academy of Sciences ·Jong‐Dae Lee, Tsung‐Hsien Chuang, Vanessa Redecke, Liping She, Paula M. Pitha, Dennis A. Carson, Eyal Raz, Howard B. Cottam	479
16	A Subset of Toll-Like Receptor Ligands Induces Cross-presentation by Bone Marrow-Derived Dendritic Cells 2003 ·The Journal of Immunology ·Sandip K. Datta, Vanessa Redecke, Kiley R. Prilliman, Kenji Takabayashi, Maripat Corr, Thomas C. Tallant, (unknown), Roman Dziarski, Shizuo Akira, Stephen P. Schoenberger, Eyal Raz	255
17	Activation of the immune system by bacterial CpG‐DNA 2002 ·Immunology ·Georg Häcker, Vanessa Redecke, Hans Häcker	109
18	Predominant Role of Toll-Like Receptor 2 Versus 4 in Chlamydia pneumoniae -Induced Activation of Dendritic Cells 2001 ·The Journal of Immunology ·(unknown), Carsten J. Kirschning, Susanne Dürr, (unknown), (unknown), Korbinian Brand, Vanessa Redecke, Hermann Wagner, Thomas Miethke	146
19	Bacterial CpG-DNA Triggers Activation and Maturation of Human CD11c−, CD123+ Dendritic Cells 2001 ·The Journal of Immunology ·(unknown), Vanessa Redecke, Joachim W. Ellwart, (unknown), Jean-Pierre Kremer, Hermann Wagner, Grayson B. Lipford	252
20	Interaction of Chlamydia pneumoniae and Human Alveolar Macrophages: Infection and Inflammatory Response 1998 ·American Journal of Respiratory Cell and Molecular Biology ·Vanessa Redecke, Klaus Dalhoff, Sabine Bohnet, Jörg Braun, Matthias Maass	94

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact